Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines.

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Cardiovascular Disease

Background:

• Preeclampsia is a growing concern globally, linked to delayed childbearing, obesity, and vascular issues in developed nations.
• Inadequate prenatal care contributes to its high prevalence in developing regions.
• Traditionally viewed as transient, preeclampsia is now recognized as a systemic disease with long-term cardiovascular implications.

Purpose of the Study:

• To review current understanding of preeclampsia pathogenesis.
• To detail updated definitions, classifications, and treatment targets for hypertensive disorders of pregnancy.
• To summarize recent advancements in preeclampsia prevention and management.

Main Methods:

• Literature review of recent concepts in preeclampsia pathogenesis.
• Analysis of updated guidelines from global obstetric and hypertensive societies.
• Synthesis of information on upstream triggers and systemic effects.

Main Results:

• Exploration of novel pathogenic pathways including heme oxygenase, hydrogen sulfide, autoantibodies, misfolded proteins, nitric oxide, and oxidative stress.
• Presentation of revised definitions and classification systems for hypertensive disorders of pregnancy.
• Emphasis on preeclampsia as a systemic condition with endothelial damage and future cardiovascular risk.

Conclusions:

• Preeclampsia is a systemic disease with lasting effects beyond delivery.
• Updated understanding aids in improved care for at-risk women, both pre- and post-delivery.
• Continued research into pathogenesis and management is vital for reducing maternal and fetal morbidity and mortality.